Squarepoint Ops LLC Hepion Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$1.77 - $2.98 $198,201 - $333,694	-111,978 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.58 - $3.64 $152,397 - $351,092	96,454 Added 621.32%	111,978 $245,000
Q3 2020 Nov 16, 2020	BUY	$2.84 - $4.59 $7,506 - $12,131	2,643 Added 20.52%	15,524 $48,000
Q2 2020 Aug 14, 2020	BUY	$1.31 - $3.09 $16,874 - $39,802	12,881 New	12,881 $37,000

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $45.7M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.